Healthcare provider profile · identity verified

Michael J Prete, MD

Internal Medicine · AUSTIN, TX · NPI 1417962580

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	404	106
Amlodipine Besylate	Amlodipine Besylate	333	93
Levothyroxine Sodium	Levothyroxine Sodium	320	80
Rosuvastatin Calcium	Rosuvastatin Calcium	260	74
Lisinopril	Lisinopril	223	55
Pravastatin Sodium	Pravastatin Sodium	208	58
Losartan Potassium	Losartan Potassium	188	52
Gabapentin	Gabapentin	171	44
Pantoprazole Sodium	Pantoprazole Sodium	161	37
Metoprolol Succinate	Metoprolol Succinate	160	37
Omeprazole	Omeprazole	156	44
Metformin Hcl Er	Metformin Hcl	146	41
Alprazolam	Alprazolam	136	28
Meloxicam	Meloxicam	128	40
Bupropion Xl	Bupropion Hcl	122	27
Tamsulosin Hcl	Tamsulosin Hcl	120	37
Potassium Chloride	Potassium Chloride	118	36
Simvastatin	Simvastatin	105	27
Zolpidem Tartrate	Zolpidem Tartrate	105	16
Hydrochlorothiazide	Hydrochlorothiazide	104	33
Sertraline Hcl	Sertraline Hcl	102	28
Trazodone Hcl	Trazodone Hcl	93	24
Albuterol Sulfate Hfa	Albuterol Sulfate	90	38
Metformin Hcl	Metformin Hcl	90	21
Fluticasone Propionate	Fluticasone Propionate	87	30
Glipizide Er	Glipizide	83	20
Montelukast Sodium	Montelukast Sodium	80	21
Escitalopram Oxalate	Escitalopram Oxalate	73	20
Temazepam	Temazepam	73	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	14
Januvia	Sitagliptin Phosphate	67	15
Allopurinol	Allopurinol	65	19
Azithromycin	Azithromycin	65	59
Carvedilol	Carvedilol	64	13
Furosemide	Furosemide	61	18
Glipizide	Glipizide	58	13
Prednisone	Prednisone	58	45
Ozempic	Semaglutide	55	11
Eliquis	Apixaban	54	11
Metoprolol Tartrate	Metoprolol Tartrate	54	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	22
Duloxetine Hcl	Duloxetine Hcl	49	11
Synthroid	Levothyroxine Sodium	47	11
Azelastine Hcl	Azelastine Hcl	43	16
Celecoxib	Celecoxib	43	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	38	11
Zolpidem Tartrate Er	Zolpidem Tartrate	38	suppressed
Benazepril Hcl	Benazepril Hcl	37	suppressed
Cefdinir	Cefdinir	36	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	32
Clonazepam	Clonazepam	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Irbesartan	Irbesartan	32	suppressed
Alendronate Sodium	Alendronate Sodium	29	11
Fenofibrate	Fenofibrate	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	14
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Atenolol	Atenolol	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Ramipril	Ramipril	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	16
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	12
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Acyclovir	Acyclovir	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Famotidine	Famotidine	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	13
Estradiol	Estradiol	16	suppressed
Etodolac	Etodolac	16	suppressed
Valsartan	Valsartan	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Colchicine	Colchicine	15	suppressed
Mupirocin	Mupirocin	15	14
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Alprazolam Er	Alprazolam	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Finasteride	Finasteride	13	suppressed
Testosterone	Testosterone	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Aliskiren	Aliskiren Hemifumarate	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	11
Diazepam	Diazepam	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error